Valuation: Qiagen N.V.

Capitalization 10.26B 8.87B 8.35B 7.55B 13.97B 879B 15.74B 96.99B 37.87B 404B 38.5B 37.69B 1,475B P/E ratio 2025 *
24.7x
P/E ratio 2026 * 22.3x
Enterprise value 10.65B 9.2B 8.66B 7.84B 14.5B 912B 16.33B 101B 39.29B 419B 39.95B 39.11B 1,531B EV / Sales 2025 *
5.16x
EV / Sales 2026 * 4.64x
Free-Float
97.04%
Yield 2025 *
0.11%
Yield 2026 * 0.11%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.43%
1 week+4.02%
Current month+5.01%
1 month+10.31%
3 months+20.28%
6 months+0.25%
Current year+3.47%
More quotes
1 week 45.59
Extreme 45.59
47.4
1 month 41.11
Extreme 41.11
47.4
Current year 37.63
Extreme 37.63
49.3
1 year 37.63
Extreme 37.63
49.3
3 years 36.84
Extreme 36.8377
54.27
5 years 36.84
Extreme 36.8377
62.56
10 years 21.96
Extreme 21.9573
62.56
More quotes
Manager TitleAgeSince
Chief Executive Officer 61 2019-10-06
Director of Finance/CFO 57 2003-12-31
Chief Operating Officer - 2022-03-31
Director TitleAgeSince
Director/Board Member 70 2003-12-31
Director/Board Member 76 2011-05-31
Chairman 67 2020-08-20
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.43%+4.02%+4.17%-0.42% 10.26B
-0.50%+1.29%+20.72%+11.61% 50.66B
+0.19%+7.98%-26.82%-23.26% 27.53B
+1.05%+4.51%-4.60%+16.70% 26.72B
-0.96%+2.54%+12.52%-25.01% 12.56B
+0.64%+21.43% - - 12.33B
+1.06%+9.10%-54.00%-32.91% 11.69B
-1.44%+4.71%-81.49%-78.48% 10.58B
-0.47%-3.73%+30.20%+106.47% 10.32B
+0.56%+3.55%-24.70%+118.69% 8.74B
Average -0.03%+6.15%-13.78%+10.38% 18.14B
Weighted average by Cap. -0.05%+5.88%-5.97%+5.89%
See all sector performances

Financials

2025 *2026 *
Net sales 2.07B 1.78B 1.68B 1.52B 2.81B 177B 3.17B 19.52B 7.62B 81.27B 7.75B 7.59B 297B 2.19B 1.89B 1.78B 1.61B 2.99B 188B 3.36B 20.72B 8.09B 86.27B 8.23B 8.05B 315B
Net income 429M 370M 349M 315M 584M 36.7B 657M 4.05B 1.58B 16.86B 1.61B 1.57B 61.59B 470M 406M 382M 346M 639M 40.21B 720M 4.44B 1.73B 18.47B 1.76B 1.72B 67.49B
Net Debt 386M 334M 314M 284M 526M 33.07B 592M 3.65B 1.42B 15.19B 1.45B 1.42B 55.51B -80.65M -69.68M -65.6M -59.36M -110M -6.91B -124M -762M -298M -3.17B -303M -296M -11.59B
More financial data * Estimated data
Logo Qiagen N.V.
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Employees
5,700
Calendar
More about the company
Date Price Change Volume
25-06-12 47.39 $ +1.43% 1,102,841
25-06-11 46.72 $ +1.08% 1,443,360
25-06-10 46.22 $ +0.11% 1,806,933
25-06-09 46.17 $ +1.52% 1,842,962
25-06-06 45.48 $ -0.18% 1,055,930

Delayed Quote Nyse, June 12, 2025 at 04:00 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
47.39USD
Average target price
49.35USD
Spread / Average Target
+4.15%
Consensus

Quarterly revenue - Rate of surprise